Nepedia
Back to Discover
Advanced Reader
🧬

Eosinophil

life science Maturity 9-11 Next article →

Eosinophils are a specialized type of white blood cell within the vertebrate immune system. They belong to a group of cells known as granulocytes. These cells are essential for combating multicellular parasites, such as helminths, which are parasitic worms. Eosinophils also play a role in fighting certain viral infections. Beyond fighting invaders, they work alongside mast cells and basophils to manage allergic responses and asthma.

Reference ranges for blood tests - white blood cells
Reference ranges for blood tests - white blood cells

The development of an eosinophil is a precise biological process. It begins during hematopoiesis, which is the production of blood cells in the bone marrow. Myeloid precursor cells begin to differentiate into eosinophils under the influence of specific signals. One critical signal is interleukin-5 (IL-5), a cytokine that controls their development. Other transcription factors, such as GATA and C/EBP, help determine their lineage fate. During this maturation, the cells produce and store many secondary granule proteins. Once they have reached terminal differentiation, they migrate into the bloodstream and can no longer multiply.

Eosinophils are named for their unique reaction to acidic dyes. They are "acidophilic," or acid-loving, because their cytoplasm contains large granules with a high affinity for acids. When scientists use the Romanowsky method to stain cells, they apply a red dye called eosin. The granules soak up this dye, making the cells appear brick-red under a microscope.

Histology of an eosinophil in esophageal epithelium
Histology of an eosinophil in esophageal epithelium

These cells typically measure between 12 and 17 micrometres in size. They are also characterized by having a bilobed nucleus, meaning the nucleus has two distinct parts.

Once mature, eosinophils move from the blood into various tissues throughout the body. They reside in several specific locations, including the spleen, lymph nodes, ovaries, uterus, and the prostate. They are also found in the thymus, specifically in the medulla and the junction between the cortex and medulla. In a healthy state, they are generally not found in the skin, lungs, or esophagus. Eosinophils persist in the circulation for about 8 to 12 hours. However, they can survive in tissues for an additional 8 to 12 days if they are not stimulated.

The primary way eosinophils fight infections is through a process called degranulation. When an eosinophil is activated by an immune stimulus, it releases the chemical mediators stored in its granules. This process can also involve cytolysis, where the cell breaks apart to release granules within extracellular DNA traps. These granules contain many toxic substances, such as major basic protein (MBP), eosinophil peroxidase (EPX), and eosinophil cationic protein (ECP). These proteins are designed to kill parasites, but they are also toxic to the host's own tissues. For example, ECP can create toxic pores in cell membranes, while EPX can cause oxidative stress that leads to cell death through apoptosis or necrosis.

Because these cells can cause tissue damage, their numbers must be carefully regulated. In a healthy individual, eosinophils make up only about 1% to 3% of all white blood cells. The median blood eosinophil count for healthy adults is approximately 100 cells/μL. If the count rises above 500 cells per microliter, the condition is called eosinophilia.

Hematopoiesis simple
Hematopoiesis simple

Eosinophilia can be caused by parasitic infestations, autoimmune diseases like systemic lupus erythematosus, or allergic conditions. In asthma, high levels of eosinophils lead to inflammation and airway remodeling, which makes breathing difficult.

Medical science has made significant progress in understanding and treating eosinophil-related issues. In the 1980s, pioneering research showed that eosinophils were unique because they could survive for long periods after maturation. Today, doctors use blood counts to predict how well certain drugs will work. Some treatments, like corticosteroids, promote apoptosis to reduce cell numbers. Other advanced therapies use monoclonal antibodies. For instance, mepolizumab and benralizumab target the IL-5 receptor to stop eosinophils from developing or to eliminate them through antibody-dependent cell-mediated cytotoxicity. Other drugs like dupilumab target IL-13 to reduce the inflammation caused by these cells.

639 words

Where will your curiosity go next?

Keep exploring at your chosen reading level.

🖼️ Images & Media (3)
File:Hematopoiesis simple.svg
Hematopoiesis simple.svg
File:Histology of an eosinophil in esophageal epithelium.jpg
Histology of an eosinophil in esophageal...
File:Reference ranges for blood tests - white blood cells.png
Reference ranges for blood tests - white...
More to explore

🔬 Go deeper

More advanced topics to explore

🪜 Step back

Simpler topics to build understanding

What is Nepedia?

A free, ad-free encyclopedia for children. Every article is written at five reading levels, so the same page works for a five-year-old and a fifteen-year-old — use the level switcher above to see this one change. No account needed to read.